Many peptides are produced either by compounding pharmacies in the U.S. or by an ever-growing number of factories in China. The most serious users tend to get peptides from the latter for both a wider ...

Revvity, Inc. is rated a Hold due to stretched valuation, ongoing weakness in China diagnostics and NIH funding. Read more on ...

After the cardboard beds of the Paris and Tokyo Olympics raised eyebrows, athletes at the 2026 Milano Cortina Games revealed ...

Hims & Hers is a Strong Buy, as shares appear historically cheap due to temporary margin compression and regulatory concerns.

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...

The cruise line said it expects double-digit revenue and adjusted earnings per share growth in 2026 on the back of 6.7% ...

The fourth quarter earnings season kicks into high gear this week, with Big Tech results from Microsoft, Meta, Tesla, and Apple headlining the earnings calendar.

Growth doesn’t have to come at the expense of clarity or well-being. When ambition is paired with thoughtful strategy, ...

Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB) jumped 4.3% in the afternoon session after several analysts upgraded the stock or raised their price targets, following the company's ...

APIA, Samoa, Jan. 14, 2026 /PRNewswire/ -- Phemex, a user-first crypto exchange, announced the launch of the Phemex Trading Bot Carnival, a global initiative with a total reward pool of up to 260,000 ...